James V. Caruso, President and CEO at Cellectar Biosciences, Inc. (CLRB), bought 4,000 shares at $1.50 ($6K) on 2015-11-19, disclosed to the SEC on 2015-11-19.
Open-market purchase of $6k CLRB by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.39 | 2,000 | $3K | 48.1% |
| 2 | $1.50 | 2,000 | $3K | 51.9% |
| Total | $1.45 avg | 4,000 | $6K | 100% |
| Filing → |
| CLRB | BUY | 2021-03-05 | $9K | — | Filing → |
| CLRB | BUY | 2020-12-28 | $50K | — | Filing → |
| CLRB | BUY | 2020-06-08 | $25K | — | Filing → |